Market Research Logo

Generics Drugs Market Research Reports & Industry Analysis

Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand name innovative drugs. These low-cost alternatives to brand-name products or generic drugs must contain the same active chemical ingredient and rate of absorption as the branded product. The chemical ingredients, along with inert substances, which aid in the body's absorption and in binding the drug, make up the composition of the drug.

The Federal Drug Administration (FDA) does not allow a generic firm to duplicate exactly the brand name formula. The generic manufacturer must alter the ingredients slightly. This is accomplished by adding inert substances, substances that are inactive, to the generic alternative. Inert substances may function as disintegrates, binders, fillers, drying agents, lubricants, coatings, wetting agents, flavorings, coloring, or drying agents. Generic drugs are often up to 50 to 80 percent cheaper than their brand name counterpart and are gaining in popularity among cost-conscious consumers and their third-party payers.

Generic drugs enter into the retail prescription industry in a two-step process. The exclusive patent protection for the brand name product must expire. As a brand name product nears patent expiration, generic competitors apply for approval to the FDA using an Abbreviated New Drug Application (ANDA). Duplicating studies of the original brand name drug is no longer required by the FDA, and many generic companies contract with specialty laboratories to conduct the bioequivalency studies regarding absorption rates. Although the majority of products must meet bioequivalence standards, bronchodilators and topical drugs cannot be measured by absorption rates and are exempt. Injectables do not require biostudies, and oral liquids are reviewed on an individual basis. The drug must receive FDA approval following this rigid testing. The FDA also conducts periodic plant site inspections and surveillance of quality control procedures.

...Show More ...Show Less


Generics Drugs Industry Research & Market Reports

  • Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2025, NAIC 325412

    ... save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $310,096 million by 2025. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry, including Average EBITDA, Operating Ratios and Sales ... Read More

  • Generics Global Industry Guide 2013-2022

    ... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Questions Answered: What was the size of the global generics market by value in 2017? What will be the ... Read More

  • Generics North America (NAFTA) Industry Guide 2013-2022

    ... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Questions Answered: What was the size of the NAFTA generics market by value in 2017? What ... Read More

  • Generics Top 5 Emerging Markets Industry Guide 2013-2022

    ... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Questions Answered: What was the size of the emerging five generics market by value ... Read More

  • Generics Global Group of Eight (G8) Industry Guide 2013-2022

    ... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Questions Answered: What was the size of the G8 generics market by value in ... Read More

  • Generics BRIC (Brazil, Russia, India, China) Industry Guide 2013-2022

    ... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Questions Answered: What was the size of the BRIC generics market by value in ... Read More

  • Generics Global Industry Almanac 2013-2022

    ... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Questions Answered: What was the size of the global generics market by value in 2017? What will be the ... Read More

  • Diagnostics and Therapeutics for HIV: Global Markets

    ... historic drug sales, regulations, reimbursements and patents. The scope of this report includes an overview of the global market scenario for diagnosis and treatments of HIV, with base year data from 2017, estimations for 2018 ... Read More

  • Global Generic Pharmaceutical Partnering Terms and Agreements 2012-2018: Deal trends, players and financials

    ... companies enter Generic Pharmaceutical partnering deals. This report provides details of the latest Generic Pharmaceutical agreements announced in the life sciences since 2012. The report takes the reader through a comprehensive review Generic Pharmaceutical deal ... Read More

  • Generics in the United Kingdom

    ... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the United Kingdom generics market. Includes market size ... Read More

  • Generics in China

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the China generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Europe

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Europe generics market. Includes market size data, textual and graphical analysis ... Read More

  • Global Generics

    ... including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Global generics market. Includes market size data, textual and graphical analysis of market ... Read More

  • Generics in India

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the India generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Italy

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Italy generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Mexico

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Mexico generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in North America

    ... of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the North America generics market. Includes market size data, textual ... Read More

  • Generics in Singapore

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Singapore generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Australia

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Australia generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Brazil

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Brazil generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in South Africa

    ... of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the South Africa generics market. Includes market size data, textual ... Read More

  • Generics in Canada

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Canada generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Asia-Pacific

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Asia-Pacific generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Spain

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Spain generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Turkey

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Turkey generics market. Includes market size data, textual and graphical analysis ... Read More

< prev 1 3 4 5 6 7 8 9

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog